Arrowstreet Capital’s Cohen & Steers CNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,058
Closed -$255K 1886
2025
Q4
$255K Buy
+4,058
New +$264K ﹤0.01% 1760
2020
Q4
Sell
-3,600
Closed -$201K 2320
2020
Q3
$201K Buy
+3,600
New +$222K ﹤0.01% 2200
2020
Q2
Sell
-52,801
Closed -$2.4M 2322
2020
Q1
$2.4M Sell
52,801
-116,083
-69% -$7.34M 0.01% 996
2019
Q4
$10.6M Buy
168,884
+114,951
+213% +$7.27M 0.02% 595
2019
Q3
$2.96M Buy
53,933
+4,698
+10% +$249K 0.01% 859
2019
Q2
$2.53M Buy
49,235
+19,070
+63% +$935K 0.01% 843
2019
Q1
$1.27M Buy
+30,165
New +$1.17M ﹤0.01% 1251
2018
Q2
Sell
-161,728
Closed -$6.58M 1110
2018
Q1
$6.58M Buy
+161,728
New +$6.79M 0.02% 523

Other funds holding CNS

Arrowstreet Capital's CNS Position: Q1 2026 in Review

Arrowstreet Capital sold out of Cohen & Steers (CNS) in Q1 2026, closing a stake of 4,058 shares — an estimated $255K sold.

Arrowstreet Capital first reported a position in CNS in Q1 2018 and held it in 8 quarters. The position peaked at $10.6M in Q4 2019. 295 funds tracked by Wall St. Rank hold CNS as of Q1 2026.

  • Arrowstreet Capital reported no remaining Cohen & Steers position as of Q1 2026 after selling out during the quarter.
  • Arrowstreet Capital sold 4,058 Cohen & Steers shares in Q1 2026, an estimated $255K.
  • Arrowstreet Capital first reported a position in Cohen & Steers in Q1 2018 and held it in 8 quarters.
  • Arrowstreet Capital's Cohen & Steers position peaked at $10.6M in Q4 2019.
  • 295 funds tracked by Wall St. Rank held Cohen & Steers as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.